drugset / Trial / NCT02029040
Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, controlled trial in the Pediatric Emergency Department. The primary objective is to determine whether nebulized 3% hypertonic saline is more effective than nebulized 0.9% saline in the treatment of bronchiolitis in the emergency department.
Timeline
- Start
- 2013-12
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 3% hypertonic saline | Unknown | 3 % | Inhaled |